Please provide your email address to receive an email when new articles are posted on . In certain settings. Whether a patient has cancer or not, we are trained to reach into our toolbox for whatever ...

From September 1999 to April 2001, 57 patients underwent allogeneic BMT or PBSC transplantation in our transplant unit. Only patients with hematological malignancies and conventional conditioning were ...

GENEVA — Colony-stimulating factors to boost white blood cell counts can be used safely in patients undergoing chemo-radiotherapy for limited-stage small cell lung cancer (LS-SCLC), although patients ...

We conducted a single institution retrospective analysis on 83 consecutive hematopoietic stem cell mobilization attempts performed in patients with MM. Among them, 56 patients had received ...

Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of febrile neutropenia in patients with cancer. This study evaluates the clinical and nonclinical value associated with G-CSFs.

Recently, concerns about the use of G-CSF during the COVID-19 pandemic have also been acknowledged by ASCO and the European Society for Medical Oncology; it was emphasized that G-CSF should be used ...

Can granulocyte colony-stimulating factor (G-CSF) stimulate leukemic cells when administered to shorten the duration of neutropenia for an acute myeloid leukemia (AML) patient in remission who is ...

Based on long-term observations, granulocyte colony-stimulating factor utilization is a safe and effective treatment to prevent infections and improve quality of life in patients with cyclic ...

In a multicenter randomized trial, we assigned patients (age range, 18 to 60 years) with newly diagnosed AML to receive cytarabine plus idarubicin (cycle 1) and cytarabine plus amsacrin (cycle 2) with ...

Practice guidelines recommend the prophylactic use of granulocyte colony–stimulating factors (G-CSFs) in patients with high risk of febrile neutropenia, but evidence suggests that G-CSFs are ...

The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...